Liu [135] constructed a CAR structure targeting and recognizing c-MET antigen using lentivirus infection and demonstrated the specificity and effectiveness of c-MET targeting CAR-NK cell immunotherapy in the treatment of human liver cancer in vitro. The gene discussed is MET; the disease is liver cancer.